Loading...

ZSQR Z SQUARED INC Dividend Policy Changes 8-K Filing

Z SQ

ZSQR

Z SQUARED INC

(ZSQR)

2024 8-K

Acquisition Announcement

Merger Announcement

Business Combination Update

Business Combination Completed

Nasdaq Approval

Management Changes

Stockholder Meeting Results

Nasdaq Compliance Issue

Merger of Equals

Management Change

Capital Structure Update

Nasdaq Compliance

Annual Meeting Results

Asset Acquisition

Acquisition Intent

Equity Purchase Agreement

Accountant Change

Nasdaq Compliance

Financial Restatement

Equity Sale and CEO Options...

Financial Restatement

Delisting Notice

Annual Meeting of Stockholders

Securities Purchase Agreement

Investment in Common Stock

Licensing Agreement and Ass...

Underwriting Agreement for ...

Presentation to Investors

Management Changes

Research Agreement with Uni...

External Links:

Coeptis Therapeutics Holdings, Inc. announced that certain financial statements from 2023 and early 2024 are no longer reliable due to accounting errors, and they plan to restate these financials.

AI Assistant

Z SQUARED INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.